NeuroTech AI
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $265M
Overview
AI-driven diagnostics company creating digital biomarkers for neurological and psychiatric conditions.
NeurosciencePsychiatry
Technology Platform
An AI/ML platform that integrates and analyzes multimodal neurological data (imaging, voice, digital behavior) to identify digital biomarkers for diagnosis and monitoring.
Funding History
2Total raised:$265M
Series C$240M
Private Equity$25M
Opportunities
Potential to become the standard of care for objective diagnosis and monitoring in neurology and psychiatry, enabling precision medicine approaches.
Risk Factors
Regulatory risk in obtaining clearance for AI-based diagnostics and commercial risk in convincing healthcare systems to adopt and pay for new diagnostic tools.
Competitive Landscape
Competes in the fragmented digital biomarker space, requiring superior clinical validation and ease of integration into clinical workflows to achieve adoption.